Management of sirolimus treatment for tumours associated with Kasabach-Merritt phenomenon

Affiliations

• ¹ Department of Dermatology and Reference Center for Genodermatoses and Rare Skin Diseases (MAGEC), University of Paris, Paris-Centre, Institut Imagine, University Hospital Necker-Enfants Malades, APHP5, Paris, France.
• ² Department of Pediatric Maxillo-Facial and Plastic Surgery, University Hospital of Necker-Enfants Malades, APHP5, Paris, France.
• ³ Department of Dermatology and Reference Center for Genodermatoses and Rare Skin Diseases (MAGEC), Universities of Nantes and Tours, INSERM 1246-SPHERE, CHRU Tours, Tours, France.
• ⁴ Department of Pharmacy, Faculté de Pharmacie, Optimisation Thérapeutique en Neuropsychopharmacologie, University Hospital Necker - Enfants Malades, University of Paris, APHP5, Paris, France.
• ⁵ INSERM UMR-S 1144, Paris, France.